 |
|
Challenging Cases in Hematologic Malignancies: Expert Perspectives in Relapsed/Refractory ALL
Read today:
www.Med-IQ.com/a721
View all Med-IQ CME/CE at www.Med-IQ.com
BECOME A MED-IQ MEMBER FOR FREE
Sign up today and access
award-winning medical education.
Learn more about your
member benefits.
Have questions?
Contact a Med-IQ Concierge Specialist. Call (toll-free)
866 858 7434 or e-mail
info@med-iq.com.
Med-IQ.
Inspiring Medical Education. |
 |
BALTIMORE, MD—September 24, 2013—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), is pleased to announce the availability of its latest CME/CE offering in oncology, Challenging Cases in Hematologic Malignancies: Expert Perspectives in Relapsed/Refractory ALL.
This interactive CME/CE initiative represents Med-IQ’s first educational activity in pediatric oncology, and its September launch date coincides with National Childhood Cancer Awareness Month.
Cancer is the leading cause of death by disease in children in the United States under the age of 15, and acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. This free, online CME/CE activity provides an update on recent advances in the treatment of relapsed/refractory pediatric ALL. It is enhanced with audio clips of faculty expert, Scott C. Howard, MD, MSc, Director of Outcome Evaluation and Morocco Programs of the International Outreach Program at St. Jude Children's Research Hospital, discussing novel therapeutic strategies being tested in current clinical trials.
"Although cure rates have increased from less than 10% to nearly 90% over the past 50 years, some patients with ALL still relapse due to the persistence of small populations of chemotherapy-resistant leukemia-initiating cells," said Dr. Howard. "This online CME/CE activity provides clinicians with the opportunity to review evidence-based strategies to manage children with relapsed ALL, and briefly reviews supportive care recommendations to optimize their outcomes."
FACULTY
 |
|
Scott C. Howard, MD, MSc
Department of Oncology
Director of Outcome Evaluation and Morocco Programs, International Outreach Program
St. Jude Children’s Research Hospital
Memphis, TN
|
Since 2008, Med-IQ has provided complimentary CME/CE activities for healthcare professionals in a variety of therapeutic areas. Med-IQ’s oncology portfolio includes education in breast cancer, colorectal cancer, high-dose methotrexate toxicities, multiple myeloma, myelodysplastic syndromes, non-small cell lung cancer, prostate cancer, stem cell mobilization, tumor lysis syndrome, and venous thromboembolism. This is Med-IQ’s first offering specific to ALL, and pediatric cancer in general.
"Med-IQ is dedicated to improving healthcare quality in the United States by providing timely, accessible, practice-focused CME/CE interventions that are relevant to clinicians' needs and address issues that will lead to better patient care," said William A. Mencia, MD, CCMEP, Vice President of Education and Medical Affairs at Med-IQ. "We are honored to play a small part in the fight against pediatric cancer by offering this educational activity to healthcare professionals, free of charge. We are hopeful that this will be the first of many pediatric cancer educational initiatives in this important field.”
This activity is approved for AMA PRA Category 1 Credit™ and CBRN credit. This activity is supported by an educational grant from Sanofi-aventis U.S. Inc., A SANOFI COMPANY.
For more information, visit www.Med-IQ.com/a721, call (toll-free) 866 858 7434, or e-mail info@med-iq.com.
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact: |
close
